RxDoctor Payments Data

Ajay Bhatnagar, MD

Radiation Oncology · Hershey, PANPI 1417161704

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (40.0%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. Bard Peripheral Vascular, Inc. accounts for 60.9% of it on its own, with 59 other manufacturers making up the rest. Among radiation oncology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$41,574in general payments, 2019–2025

Across 277 payments — averaging $150.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bard Peripheral Vascular, Inc.$25K
  • Teleflex LLC$3K
  • Palette Life Sciences, Inc.$3K
  • Isoray, Inc$2K
  • Siemens Medical Solutions USA, Inc.$1K
  • Viewray Technologies Inc$1K
  • plus $6K from 54 others
$21,525in research payments, 2019–2025

Across 1 payment — averaging $21,525 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Icad, Inc$22K

What the payments were for

  • Consulting fees$16,10039%
  • Speaking & faculty fees$6,90017%
  • Travel & lodging$1,9265%
  • Food & beverage$16,63140%
  • Education$170%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$41,574 in reported general payments places this provider in the 95th percentile of 339 radiation oncology providers in Pennsylvania.

See all radiation oncology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$183,624
Medicare patients
79
Services billed
916

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl186$2,388
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl16$267
Cephalexin58$258
Finasteride22$176
Clindamycin Hcl13$137

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Hershey

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →